CHLOPICKI; Stefan

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHLOPICKI; Stefan.The latest application filed is for "rapidly improving endothelial function, reducing arterial stiffness and reversing calcification of blood vessels by administering vitamin k".

Company Profile

3.8.20

CHLOPICKI; Stefan - Krakow PL
Chlopicki; Stefan - Cracow PL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Rapidly Improving Endothelial Function, Reducing Arterial Stiffness And Reversing Calcification Of Blood Vessels By Administering Vitamin K App 20220160651 - CHLOPICKI; Stefan ; et al.	2022-05-26
Mri Contrast Agent For Use In The Diagnosis Of Early Changes In The Endothelium Of Blood Vessels App 20220143224 - BAR; Anna ; et al.	2022-05-12
Rapidly Improving Endothelial Function, Reducing Arterial Stiffness And Reversing Calcification Of Blood Vessels By Administering Vitamin K App 20200289434 - CHLOPICKI; Stefan ; et al.	2020-09-17
Rapidly Improving Vascular Conditions By Administering Vitamin K App 20200030258 - Chlopicki; Stefan ; et al.	2020-01-30
Rapidly Improving Vascular Conditions By Administering Vitamin K App 20190328683 - CHLOPICKI; Stefan ; et al.	2019-10-31
Use of Quaternary Pyridinium Salts as Vasoprotective Agents App 20160346265 - GEBICKI; Jerzy ; et al.	2016-12-01
Method for evaluating vascular endothelium function and a system therefor Grant 9,155,472 - Gebicki , et al. October 13, 2	2015-10-13
Use of Quaternary Pyridinium Salts as Vasoprotective Agents App 20150133508 - GEBICKI; Jerzy ; et al.	2015-05-14
Use of Quaternary Pyridinium Salts as Vasoprotective Agents App 20140296305 - GEBICKI; Jerzy ; et al.	2014-10-02
1-methylnicotinaide derivatives and formulations of treatment of lipoprotein abnormalities Grant 8,481,570 - Bender , et al. July 9, 2	2013-07-09
Method For Evaluating Vascular Endothelium Function And A System Therefor App 20120310057 - Gebicki; Jerzy ; et al.	2012-12-06
Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage Grant 8,304,439 - Gebicki , et al. November 6, 2	2012-11-06
1-Methylnicotinaide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities App 20120245115 - BENDER; Robert ; et al.	2012-09-27
1-methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities Grant 8,211,922 - Bender , et al. July 3, 2	2012-07-03
Use of quaternary pyridinium salts as vasoprotective agents Grant 8,124,631 - Gebicki , et al. February 28, 2	2012-02-28
Use Quaternary Pyridinium Salts as Vasoprotective Agents App 20110245297 - GEBICKI; Jerzy ; et al.	2011-10-06
Method For Inhibiting And/or Preventing Formation Of Cancer Metastases And Secondary Malignant Cancer App 20110201653 - Gebicki; Jerzy ; et al.	2011-08-18
Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection App 20110118316 - MARCINEK; Andrzej ; et al.	2011-05-19
Method for treating hypertriglyceridemia, dyslipidemia and hypercholesterolemia with a 1-methylnicotinamide salt Grant 7,935,717 - Gebicki , et al. May 3, 2	2011-05-03
N'-nitroxyalkylnicotinamides For The Treatment Of Cardiovascular Diseases App 20110082177 - Gebicki; Jerzy ; et al.	2011-04-07
Use of Quaternary Pyridinium Salts as Vasoprotective Agents App 20100173956 - GEBICKI; Jerzy ; et al.	2010-07-08
1-Methylnicotinamide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities App 20100120726 - Bender; Robert ; et al.	2010-05-13
Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers App 20090118340 - Gebicki; Jerzy ; et al.	2009-05-07
Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection App 20080221172 - MARCINEK; Andrzej ; et al.	2008-09-11
Use of Quaternary Pyridinium Salts as Vasoprotective Agents App 20080207702 - Gebicki; Jerzy ; et al.	2008-08-28
Methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities App 20070021379 - Bender; Robert ; et al.	2007-01-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.